Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Duffull

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Drug Safety|August 3, 2019
The Association between Metformin Therapy and Lactic AcidosisIsabelle H S Kuan, Ruth L Savage, Stephen B Duffull, et al.
British Journal of Clinical Pharmacology|August 12, 2020
Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19Ricardo Peña-Silva, Stephen B Duffull, Andrew C Steer, et al.
Clinical Pharmacokinetics|March 14, 2013
A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cellsJulia Korell, Lisa K Stamp, Murray L Barclay, et al.
British Journal of Clinical Pharmacology|October 10, 2015
Predicting allopurinol response in patients with goutDaniel F B Wright, Stephen B Duffull, Tony R Merriman, et al.
The Journal of Pain|December 8, 2009
A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalinChe S Zin, Lisa M Nissen, James P O'Callaghan, et al.
British Journal of Clinical Pharmacology|July 13, 2013
Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell typesJulia Korell, Stephen B Duffull, Judith M Dalrymple, et al.
Nephrology (Carlton, Vic.)|September 3, 2011
Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoringFrederiek E Vos, John B Schollum, Carolyn V Coulter, et al.
Malaria Journal|August 7, 2009
Towards optimal design of anti-malarial pharmacokinetic studiesJulie A Simpson, Kris M Jamsen, Ric N Price, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 2011
Red blood cell survival in long-term dialysis patientsFrederiek E Vos, John B Schollum, Carolyn V Coulter, et al.
European Journal of Clinical Pharmacology|March 12, 2013
The population pharmacokinetics of allopurinol and oxypurinol in patients with goutDaniel F B Wright, Lisa K Stamp, Tony R Merriman, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Drug Safety|August 3, 2019
The Association between Metformin Therapy and Lactic AcidosisIsabelle H S Kuan, Ruth L Savage, Stephen B Duffull, et al.
British Journal of Clinical Pharmacology|August 12, 2020
Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19Ricardo Peña-Silva, Stephen B Duffull, Andrew C Steer, et al.
Clinical Pharmacokinetics|March 14, 2013
A population pharmacokinetic model for low-dose methotrexate and its polyglutamated metabolites in red blood cellsJulia Korell, Lisa K Stamp, Murray L Barclay, et al.
British Journal of Clinical Pharmacology|October 10, 2015
Predicting allopurinol response in patients with goutDaniel F B Wright, Stephen B Duffull, Tony R Merriman, et al.
The Journal of Pain|December 8, 2009
A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalinChe S Zin, Lisa M Nissen, James P O'Callaghan, et al.
British Journal of Clinical Pharmacology|July 13, 2013
Comparison of intracellular methotrexate kinetics in red blood cells with the kinetics in other cell typesJulia Korell, Stephen B Duffull, Judith M Dalrymple, et al.
Nephrology (Carlton, Vic.)|September 3, 2011
Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoringFrederiek E Vos, John B Schollum, Carolyn V Coulter, et al.
Malaria Journal|August 7, 2009
Towards optimal design of anti-malarial pharmacokinetic studiesJulie A Simpson, Kris M Jamsen, Ric N Price, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 2011
Red blood cell survival in long-term dialysis patientsFrederiek E Vos, John B Schollum, Carolyn V Coulter, et al.
European Journal of Clinical Pharmacology|March 12, 2013
The population pharmacokinetics of allopurinol and oxypurinol in patients with goutDaniel F B Wright, Lisa K Stamp, Tony R Merriman, et al.
Pageof 18